Cuts without a medical basis Laboratory reform against the laboratories and diagnostics manufacturers?

The Verband der Diagnostica-Industrie e.V. (VDGH) is deeply concerned about the latest decisions of the Evaluation Committee on the reimbursement of laboratory medical services in statutory health insurance. Massive reductions in reimbursements for laboratory tests are planned in the EBM.

The drastic cuts could threaten the existence of companies in the medium-sized IVD industry.

"It shows complete disregard for the complex laboratory diagnostic test procedures if the remuneration for them is cut with a lawnmower," says VDGH Managing Director Dr. Martin Walger. More than 500 reimbursement items are to be reduced as of January 1, 2025, at the peak by more than 70 percent compared to the current level. "There are neither medical reasons nor a cost calculation as a rational basis for this radical cut," says the VDGH. The VDGH is particularly critical of the reduction in remuneration for early detection services, also from a healthcare perspective.

The across-the-board cuts are intended to finance improvements in doctors' salaries and the costs of transportation and collection materials. "The Accredited Laboratories in Medicine (ALM e.V.) are right to describe this decision as a sham," says Walger, referring to the difficult situation of the diagnostics supply industry. Test manufacturers are facing massive cost increases for raw materials, energy and logistics. In addition, the bureaucratic burden is increasing immensely, particularly due to the new legal framework for product approval.

The VDGH is in favor of repealing the decisions of the evaluation committee and is calling for sustainable financing of the laboratory reform.

In a nutshell: The Association of the Diagnostics Industry (VDGH)

The Association of the Diagnostics Industry (VDGH) is a trade association representing the interests of more than 100 companies operating in Germany with a total turnover of 5.5 billion euros in 2024. They manufacture examination systems and reagents for the diagnosis of human diseases, which generate a turnover of more than 2.4 billion euros, as well as instruments, reagents, test systems and consumables for research in the life sciences, which generate a turnover of 3.1 billion euros.

www.vdgh.de

Your press contact

Torsten Kiesner

Press and communication

+49 30 200 599-43

This might also interest you